CD8A and neoplasm: In vivo studies reveal that CE significantly potentiates the therapeutic effect by reducing the proportion of myeloid-derived suppressor cells (MDSCs), suppressing tumor cell glycolysis, and increasing the proportions of CD8+ T cells and memory T cells.